Friday 6 November 2026 Export AKBA’s income statement to Excel — free account

Akebia Therapeutics, Inc.

AKBA Healthcare Drug Manufacturers Specialty & Generic

Akebia Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $236.2 million, up 47.5% from fiscal 2024.

Revenue: −37.2%
EPS: −2,600.0%
Free cash flow: −94.2%
Total debt: +5.52%

Quarter to September 2026, against a year earlier

Insider buying

0.41 0.02 −4.65%

Follow AKBA

Alert me

Market cap: $117.9M
P/E: 0.0×
Fwd P/E: −4.9×
Dividend yield: —
F-score: 7/9
Altman Z: −4.42
Beneish M: −3.16
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26 From the 10-Q filed 5 Nov
Piotroski F-Score Full definition →	+8 more TTM periods Free account	7	6	5	3
ROE Full definition →		64.49%	(78.96%)	(109.38%)	(143.83%)
ROA Full definition →		(1.79%)	(6.10%)	(8.53%)	(12.62%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(5.86%)	(29.07%)	(42.26%)	(73.24%)
Average Days of Receivables Full definition →		72.68	98.22	89.15	67.45
Free Cash Flow per Share Full definition →		0.26	0.22	0.15	0.05
Free Cash Flow Full definition →		67.87	60.04	40.26	13.86
Capital Expenditures Full definition →		(0.12)	(0.33)	(1.29)	(1.92)
Other line items
Cash ROIC Full definition →		25.54%	25.13%	17.50%	6.03%
Accounts Receivable Turnover Full definition →		5.80	3.75	3.47	3.84
Accounts Payable Turnover Full definition →		2.17	4.19	4.26	4.70
Inventory Turnover Full definition →		2.48	2.70	3.00	2.23
Average Days of Payables Full definition →		195.95	69.37	77.05	66.77
Days of Inventory on Hand Full definition →		144.38	107.50	106.46	164.05
Tax Rate Full definition →		(0.38)	0.00	0.07	0.03
Research and Development Expense of Revenue Full definition →		26.40%	29.01%	32.16%	36.36%
Selling, General and Administrative Expense of Revenue Full definition →		45.50%	48.27%	51.94%	54.88%
Share Based Compensation of Revenue Full definition →		4.78%	5.49%	6.08%	6.54%
Interest Coverage Full definition →		0.97	0.25	(0.87)	(1.97)
Operating CF/Net income Full definition →		(12.72)	(2.94)	(1.40)	(0.35)
Depreciation/Fixed assets Full definition →		1.04	1.34	1.03	0.00
Capex/Depreciation Full definition →		(0.09)	(0.26)	(0.83)	0.00
Revenue per Share Full definition →		0.92	0.87	0.81	0.71
Operating CF per Share Full definition →		0.26	0.23	0.15	0.06
Capex per Share Full definition →		0.00	0.00	0.00	(0.01)
Capex to Sales Full definition →		0.00	0.00	0.01	0.01

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly